Kumar R, Park J H, O'Brien P Q. "Method for the Synthesis of Upadacitinib Impurity 97" [P]. US Patent, US 10532010 B2, 2016-07-16.
发明人郑宇鹏,高志强,赵玉洁. "A Process for Preparing High-Purity Upadacitinib Impurity 97" [P]. 中国发明专利, 专利号 CN 108779517 B, 授权公告日 2022-12-18.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质97 in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 1270, (3), 5923-5933.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质97 as an Impurity". Sci. Total Environ., 2019, 487, (10), 8062-8082.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 97 Using HRMS and NMR". J. Nat. Prod., 2014, 1703, 3993-4003.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 乌帕替尼杂质97 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2013, 2422, (7), 4460-4485.